These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20739682)

  • 1. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.
    Picard D; Janela B; Descamps V; D'Incan M; Courville P; Jacquot S; Rogez S; Mardivirin L; Moins-Teisserenc H; Toubert A; Benichou J; Joly P; Musette P
    Sci Transl Med; 2010 Aug; 2(46):46ra62. PubMed ID: 20739682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro.
    Mardivirin L; Valeyrie-Allanore L; Branlant-Redon E; Beneton N; Jidar K; Barbaud A; Crickx B; Ranger-Rogez S; Descamps V
    Eur J Dermatol; 2010; 20(1):68-73. PubMed ID: 19822481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.
    Descamps V; Valance A; Edlinger C; Fillet AM; Grossin M; Lebrun-Vignes B; Belaich S; Crickx B
    Arch Dermatol; 2001 Mar; 137(3):301-4. PubMed ID: 11255328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
    Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
    Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study.
    Chen YC; Chiang HH; Cho YT; Chang CY; Chen KL; Yang CW; Lee YH; Chu CY
    Allergy; 2015 May; 70(5):568-75. PubMed ID: 25727950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.
    Eshki M; Allanore L; Musette P; Milpied B; Grange A; Guillaume JC; Chosidow O; Guillot I; Paradis V; Joly P; Crickx B; Ranger-Rogez S; Descamps V
    Arch Dermatol; 2009 Jan; 145(1):67-72. PubMed ID: 19153346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation].
    Funck-Brentano E; Duong T; Family D; Bouaziz JD; Ortonne N; Bagot M; Roujeau JC; Wolkenstein P; Valeyrie-Allanore L
    Ann Dermatol Venereol; 2011; 138(8-9):580-5. PubMed ID: 21893231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
    Clave E; Agbalika F; Bajzik V; Peffault de Latour R; Trillard M; Rabian C; Scieux C; Devergie A; Socié G; Ribaud P; Adès L; Ferry C; Gluckman E; Charron D; Esperou H; Toubert A; Moins-Teisserenc H
    Transplantation; 2004 Jan; 77(1):76-84. PubMed ID: 14724439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug rash with eosinophilia and systemic symptoms (DRESS): changing carbamazepine to phenobarbital controlled epilepsy without the recurrence of DRESS.
    Inadomi T
    Eur J Dermatol; 2010; 20(2):220-2. PubMed ID: 20103499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug reaction with eosinophilia and systemic symptoms (DRESS)].
    Descamps V
    Rev Prat; 2012 Dec; 62(10):1347-52. PubMed ID: 23424909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study.
    Berthelot JM; Saulquin X; Coste-Burel M; Peyrat MA; Echasserieau K; Bonneville M; Houssaint E
    J Rheumatol; 2003 Aug; 30(8):1673-9. PubMed ID: 12913921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
    Plotnicky H; Touraine JL
    Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Six cases of spring DRESS].
    Bollaert M; Jeulin H; Waton J; Gastin I; Tréchot P; Rabaud C; Schmutz JL; Barbaud A
    Ann Dermatol Venereol; 2012 Jan; 139(1):15-22. PubMed ID: 22225738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
    Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Tohyama M; Hashimoto K; Oda F; Namba C; Sayama K
    J Dermatol; 2020 May; 47(5):476-482. PubMed ID: 32162382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).
    Descamps V; Avenel-Audran M; Valeyrie-Allanore L; Bensaid B; Barbaud A; Al Jawhari M; Ranger-Rogez S;
    JAMA Dermatol; 2013 May; 149(5):565-9. PubMed ID: 23426332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
    Walsh S; Diaz-Cano S; Higgins E; Morris-Jones R; Bashir S; Bernal W; Creamer D
    Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.